These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 27515958)

  • 21. Sea buckthorn (Hippophae rhamnoides L.) fermentation liquid protects against alcoholic liver disease linked to regulation of liver metabolome and the abundance of gut microbiota.
    Ran B; Guo CE; Li W; Li W; Wang Q; Qian J; Li H
    J Sci Food Agric; 2021 May; 101(7):2846-2854. PubMed ID: 33145761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microbiota-based treatments in alcoholic liver disease.
    Sung H; Kim SW; Hong M; Suk KT
    World J Gastroenterol; 2016 Aug; 22(29):6673-82. PubMed ID: 27547010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MUP1 mediates urolithin A alleviation of chronic alcohol-related liver disease via gut-microbiota-liver axis.
    Zhang H; Li C; Han L; Xiao Y; Bian J; Liu C; Gong L; Liu Z; Wang M
    Gut Microbes; 2024; 16(1):2367342. PubMed ID: 38889450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut non-bacterial microbiota contributing to alcohol-associated liver disease.
    Gao W; Zhu Y; Ye J; Chu H
    Gut Microbes; 2021; 13(1):1984122. PubMed ID: 34711112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut-liver axis and sterile signals in the development of alcoholic liver disease.
    Szabo G; Petrasek J
    Alcohol Alcohol; 2017 Jul; 52(4):414-424. PubMed ID: 28482064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gut microbiota-based machine-learning signature for the diagnosis of alcohol-associated and metabolic dysfunction-associated steatotic liver disease.
    Park IG; Yoon SJ; Won SM; Oh KK; Hyun JY; Suk KT; Lee U
    Sci Rep; 2024 Jul; 14(1):16122. PubMed ID: 38997279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microbiota, Liver Diseases, and Alcohol.
    Cassard AM; Gérard P; Perlemuter G
    Microbiol Spectr; 2017 Aug; 5(4):. PubMed ID: 28840806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intestinal dysbiosis and permeability: the yin and yang in alcohol dependence and alcoholic liver disease.
    Stärkel P; Leclercq S; de Timary P; Schnabl B
    Clin Sci (Lond); 2018 Jan; 132(2):199-212. PubMed ID: 29352076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Role of Gut-Derived Lipopolysaccharides and the Intestinal Barrier in Fatty Liver Diseases.
    An L; Wirth U; Koch D; Schirren M; Drefs M; Koliogiannis D; Nieß H; Andrassy J; Guba M; Bazhin AV; Werner J; Kühn F
    J Gastrointest Surg; 2022 Mar; 26(3):671-683. PubMed ID: 34734369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flaxseed oil ameliorates alcoholic liver disease via anti-inflammation and modulating gut microbiota in mice.
    Zhang X; Wang H; Yin P; Fan H; Sun L; Liu Y
    Lipids Health Dis; 2017 Feb; 16(1):44. PubMed ID: 28228158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Camel milk modulates ethanol-induced changes in the gut microbiome and transcriptome in a mouse model of acute alcoholic liver disease.
    Ming L; Qiao X; Yi L; Siren D; He J; Hai L; Guo F; Xiao Y; Ji R
    J Dairy Sci; 2020 May; 103(5):3937-3949. PubMed ID: 32171514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Host Factors in Dysregulation of the Gut Barrier Function during Alcohol-Associated Liver Disease.
    Maccioni L; Leclercq IA; Schnabl B; Stärkel P
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alcoholic liver disease and intestinal microbiota in an experimental model: Biochemical, inflammatory, and histologic parameters.
    Thoen RU; Longo L; Leonhardt LC; Pereira MHM; Rampelotto PH; Cerski CTS; Álvares-da-Silva MR
    Nutrition; 2023 Feb; 106():111888. PubMed ID: 36436334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice.
    Hartmann P; Hochrath K; Horvath A; Chen P; Seebauer CT; Llorente C; Wang L; Alnouti Y; Fouts DE; Stärkel P; Loomba R; Coulter S; Liddle C; Yu RT; Ling L; Rossi SJ; DePaoli AM; Downes M; Evans RM; Brenner DA; Schnabl B
    Hepatology; 2018 Jun; 67(6):2150-2166. PubMed ID: 29159825
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Zhong X; Cui P; Jiang J; Ning C; Liang B; Zhou J; Tian L; Zhang Y; Lei T; Zuo T; Ye L; Huang J; Chen H
    Front Cell Infect Microbiol; 2021; 11():649060. PubMed ID: 33816353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting the gut microbiota to treat alcoholic liver diseases: evidence and promises.
    Leclercq S; de Timary P; Stärkel P
    Acta Gastroenterol Belg; 2020; 83(4):616-621. PubMed ID: 33321019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbiome Alterations in Alcohol Use Disorder and Alcoholic Liver Disease.
    Litwinowicz K; Gamian A
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature.
    Milosevic I; Vujovic A; Barac A; Djelic M; Korac M; Radovanovic Spurnic A; Gmizic I; Stevanovic O; Djordjevic V; Lekic N; Russo E; Amedei A
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30658519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microbiome-Based Metabolic Therapeutic Approaches in Alcoholic Liver Disease.
    Hyun JY; Kim SK; Yoon SJ; Lee SB; Jeong JJ; Gupta H; Sharma SP; Oh KK; Won SM; Kwon GH; Cha MG; Kim DJ; Ganesan R; Suk KT
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic manipulation of gut microbiota by polysaccharides of
    Sun S; Wang K; Sun L; Cheng B; Qiao S; Dai H; Shi W; Ma J; Liu H
    Gut Microbes; 2020 Nov; 12(1):1830693. PubMed ID: 33106075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.